Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2016 Jun 18

PMID 27313612

Citations 12

Authors

Lin-Zheng He

Tian-Shu Zeng

Lin Pu

Shi-Xiu Pan

Wen-Fang Xia

Lu-Lu Chen

Affiliations

Soon will be listed here.

Abstract

Our objective was to evaluate thyroid nodule malignancy prediction using thyroid function tests, autoantibodies, ultrasonographic imaging, and clinical data. We conducted a retrospective cohort study in 1400 patients with nodular thyroid disease (NTD). The thyroid stimulating hormone (TSH) concentration was significantly higher in patients with differentiated thyroid cancer (DTC) versus benign thyroid nodular disease (BTND) (p = 0.004). The receiver operating characteristic curve of TSH showed an AUC of 0.58 (95% CI 0.53-0.62, p = 0.001), sensitivity of 74%, and specificity of 57% at a cut-off of 1.59 mIU/L. There was an incremental increase in TSH concentration along with the increasing tumor size (p < 0.001). Thyroglobulin antibody (TgAb) concentration was associated with an increased risk of malignancy (p = 0.029), but this association was lost when the effect of TSH was taken into account (p = 0.11). Thyroid ultrasonographic characteristics, including fewer than three nodules, hypoechoic appearance, solid component, poorly defined margin, intranodular or peripheral-intranodular flow, and punctate calcification, can be used to predict the risk of thyroid cancer. In conclusion, our study suggests that preoperative serum TSH concentration, age, and ultrasonographic features can be used to predict the risk of malignancy in patients with NTD.

Citing Articles

Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation.

Yuan K, Hu D, Mo X, Zeng R, Wu B, Zhang Z Aging (Albany NY). 2023; 15(17):8729-8743.

PMID: 37671970 PMC: 10522395. DOI: 10.18632/aging.204993.

Patterns of Thyroid Cancer Mortality and Incidence in Saudi Arabia: A 30-Year Study.

Flemban A, Kabrah S, Alahmadi H, Alqurashi R, Turaes A, Almaghrabi R Diagnostics (Basel). 2022; 12(11).

PMID: 36359559 PMC: 9689402. DOI: 10.3390/diagnostics12112716.

The prevalence and associated predictors for Bethesda III-VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia.

Alyousif H, Adam I, Alamin N, Ahmed M, Al Saeed A, Hassoni A Ther Adv Endocrinol Metab. 2022; 13:20420188221122486.

PMID: 36111207 PMC: 9469765. DOI: 10.1177/20420188221122486.

The Future of Thyroid Nodule Risk Stratification.

Burgos N, Ospina N, Sipos J Endocrinol Metab Clin North Am. 2022; 51(2):305-321.

PMID: 35662443 PMC: 10314730. DOI: 10.1016/j.ecl.2021.12.002.

SLCO4A1 is a Prognosis-Associated Biomarker Involved in Neutrophil-Mediated Immunity in Thyroid Cancer.

Wang X, Wu S, Peng Z, Zhu H Int J Gen Med. 2021; 14:9615-9628.

PMID: 34924768 PMC: 8674671. DOI: 10.2147/IJGM.S339921.

References

CRILE Jr G . Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet. 1978; 147(3):350-2. View

McHenry C, Huh E, Machekano R . Is nodule size an independent predictor of thyroid malignancy?. Surgery. 2008; 144(6):1062-8. DOI: 10.1016/j.surg.2008.07.021. View

Zhang L, Li H, Ji Q, Zhu Y, Wang Z, Wang Y . The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease. BMC Cancer. 2012; 12:610. PMC: 3547693. DOI: 10.1186/1471-2407-12-610. View

Unger P, Ewart M, Wang B, Gan L, Kohtz D, Burstein D . Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?. Hum Pathol. 2003; 34(8):764-9. DOI: 10.1016/s0046-8177(03)00239-9. View

Raber W, Kaserer K, Niederle B, Vierhapper H . Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 2000; 10(8):709-12. DOI: 10.1089/10507250050137806. View

Fiore E, Rago T, Latrofa F, Provenzale M, Piaggi P, Delitala A . Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer. 2011; 18(4):429-37. DOI: 10.1530/ERC-11-0028. View

Boelaert K, Horacek J, Holder R, Watkinson J, Sheppard M, Franklyn J . Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006; 91(11):4295-301. DOI: 10.1210/jc.2006-0527. View

Kim E, Park C, Chung W, Oh K, Kim D, Lee J . New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol. 2002; 178(3):687-91. DOI: 10.2214/ajr.178.3.1780687. View

Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose N . Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer. 1995; 76(11):2312-8. DOI: 10.1002/1097-0142(19951201)76:11<2312::aid-cncr2820761120>3.0.co;2-h. View

10.

Holm L, Blomgren H, Lowhagen T . Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985; 312(10):601-4. DOI: 10.1056/NEJM198503073121001. View

11.

Guarino V, Castellone M, Avilla E, Melillo R . Thyroid cancer and inflammation. Mol Cell Endocrinol. 2009; 321(1):94-102. DOI: 10.1016/j.mce.2009.10.003. View

12.

McHenry C, Walfish P, Rosen I . Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg. 1993; 59(7):415-9. View

13.

Zafon C, Obiols G, Baena J, Castellvi J, Dalama B, Mesa J . Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of larger size. J Thyroid Res. 2011; 2012:530721. PMC: 3154785. DOI: 10.1155/2012/530721. View

14.

Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latrofa F . Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf). 2007; 67(3):363-9. DOI: 10.1111/j.1365-2265.2007.02892.x. View

15.

Kihara M, Hirokawa M, Masuoka H, Yabuta T, Shindo H, Higashiyama T . Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases. Auris Nasus Larynx. 2012; 40(3):308-11. DOI: 10.1016/j.anl.2012.09.007. View

16.

Anil G, Hegde A, Chong F . Thyroid nodules: risk stratification for malignancy with ultrasound and guided biopsy. Cancer Imaging. 2011; 11:209-23. PMC: 3266587. DOI: 10.1102/1470-7330.2011.0030. View

17.

Castro M, Espiritu R, Bahn R, Henry M, Gharib H, Caraballo P . Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011; 21(11):1191-8. PMC: 3208245. DOI: 10.1089/thy.2011.0146. View

18.

Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View

19.

Alexander E, Hurwitz S, Heering J, Benson C, Frates M, Doubilet P . Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003; 138(4):315-8. DOI: 10.7326/0003-4819-138-4-200302180-00010. View

20.

Tan G, Gharib H . Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997; 126(3):226-31. DOI: 10.7326/0003-4819-126-3-199702010-00009. View